Fierce Pharma

SEPTEMBER 30, 2024

After putting on a strong performance in preventing disease progression in the earlier treatment of multiple myeloma, Johnson & Johnson and Legend Biotech’ Carvykti has once again mounted a maj | After putting on a strong performance in preventing disease progression, Johnson & Johnson and Legend Biotech’s Carvykti has once again demonstrated a major benefit—this time in prolonging patients’ lives.

Leads 324

Leads Patients 324

MedCity News

SEPTEMBER 30, 2024

In this month’s episode, Senior Reporter Katie Adams explored some of the executive moves, exits and layoffs that recently occurred in the healthcare sector. She also interviewed Dr. Jayne Morgan, who recently became vice president of medical affairs at Hello Heart. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Dr. Jayne Morgan, VP of Medical Affairs at Hello Heart appeared first on MedCity News.

Medical 128

Medical Healthcare Healthcare 128

Fierce Pharma

SEPTEMBER 30, 2024

After experiencing a series of ups and downs in recent years, the biopharma contracting business is gearing up for a rebound in 2025. | Ahead of the CPHI conference in Milan, the events group has teased new research signaling an expected rebound for the CDMO industry—and a rejection of the BIOSECURE Act.

Biopharma 321

Biopharma 321

MedCity News

SEPTEMBER 30, 2024

Memorial Hermann Health System and Moffitt Cancer Center have recently struck partnerships with Reimagine Care, a startup focused on providing support to cancer patients via an AI assistant and text messages with oncology experts. The post Health Systems Are Partnering with Reimagine Care to Improve Cancer Treatment appeared first on MedCity News.

Patients 122

Patients 122

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

SEPTEMBER 30, 2024

With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ultra-rare disease. | With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ultra-rare disease. Still, with months of prep work and outreach complete, the company is already proving it can hit the ground running.

Marketing 246

Marketing 246

MedCity News

SEPTEMBER 30, 2024

By embracing available data, cutting-edge technology, and an intelligent marketplace, payers can design solutions that optimize costs across the entire healthcare ecosystem. The post Payers Possess the Tools to Tackle Rising Healthcare Costs appeared first on MedCity News.

Healthcare 117

Healthcare Healthcare 117

pharmaphorum

SEPTEMBER 30, 2024

Chiesi Biotech Center of Excellence opens to strengthen R&D in Italy Nicole.

111

111

Pharmaceutical Commerce

SEPTEMBER 30, 2024

Why looming benefit changes—and the resulting unintended consequences—are a concern for patients.

Patients 110

Patients 110

pharmaphorum

SEPTEMBER 30, 2024

Genentech buys Regor's next-gen CDK inhibitors for $850M Jonah.

111

111

MedCity News

SEPTEMBER 30, 2024

Healthy Young Minds is an online youth mental health startup. It was recently crowned winner of MedCity News’ INVEST Pitch Perfect contest focused on pediatric mental health. The post INVEST Pitch Perfect Spotlight: How One Startup Aims To Become the Leading Medicaid Mental Health Provider for Kids appeared first on MedCity News.

Leads 110

Leads 110

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

SEPTEMBER 30, 2024

The first needle-free epinephrine nasal spray, Neffy by ARS Pharmaceuticals, represents a significant breakthrough in emergency treatment for type I allergic reactions.

Patients 105

Patients Pharmaceutical 105

MedCity News

SEPTEMBER 30, 2024

Bristol Myers Squibb is turning to the prime-editing technology of Prime Medicines for the R&D of new cell therapies for cancer and immunology. The pharma giant is paying $110 million up front to begin the collaboration. The post Gene-Editing Biotech Prime Medicine Strikes Up Cell Therapy R&D Alliance With Bristol Myers Squibb appeared first on MedCity News.

Medicine 110

Medicine Pharma Biopharma 110

PharmaVoice

SEPTEMBER 30, 2024

The company’s allogeneic therapy was OK’d in the EU and could become the first of its kind approved by the FDA in January — while eyeing the next frontier.

FDA 98

FDA 98

Pharmaceutical Commerce

SEPTEMBER 30, 2024

Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.

Prescription 95

Prescription 95

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

SEPTEMBER 30, 2024

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

Patients 69

Patients 69

European Pharmaceutical Review

SEPTEMBER 30, 2024

177 Lu-Dotatate has shown potential for extending progression-free survival for patients with the brain cancer meningioma, with results showing more favourable improvements compared to historical benchmarks. The Phase II clinical trial investigated whether refractory meningioma can be treated with theranostics. This treatment approach uses radiopharmaceuticals and provides patients with potentially a more effective treatment option, the researchers explained.

Patients 64

Patients Safety Medicine Pharmaceutical 64

Pharmaceutical Technology

SEPTEMBER 30, 2024

Medidata is a winner in the Innovation, and Product Launches categories in the 2024 Pharmaceutical Technology Excellence Awards.

Pharmaceutical 69

Pharmaceutical 69

Pharmaceutical Commerce

SEPTEMBER 30, 2024

Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.

Marketing 59

Marketing 59

Advertisement

Pharmaceutical Technology

SEPTEMBER 30, 2024

The European Commission approved Johnson and Johnson’s Yuvanci as the first single-pill combination therapy for PAH.

59

59

PM360

SEPTEMBER 30, 2024

Digital disruption in the pharma sector is being slowed down by budget constraints, and that does not seem like it’s going to change any time soon, according to new research from digital experience agency Graphite Digital. The Disconnected Pharma report reveals pharma companies are keen on strengthening their digital capabilities and offerings, setting a foundation for them to build upon as their customers’ needs change and new technologies emerge. 37 percent of pharma leaders want to ensure tha

Pharma 59

Pharma Management Patients 59

Pharmacy Times

SEPTEMBER 30, 2024

MDL-101 is a proposed novel precision medicine that targets the LAMA1 gene, causing LAMA2 congenital muscular dystrophy type 1a.

Medicine 58

Medicine FDA 58

PM360

SEPTEMBER 30, 2024

for Your Brand, Company, or the Industry as a Whole Building trust equity in the pharmaceutical industry hinges on a commitment to transparency, reliability, and ethical practices. Engaging with healthcare professionals and patients through educational initiatives and open dialogue helps to demystify complex information and foster a sense of reliability between the two.

Ethics 59

Ethics Pharma Side effects Healthcare 59

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmacy Times

SEPTEMBER 30, 2024

The guidelines mark a shift in practice by recommending a multimodal approach to opioid prescribing practices.

Prescription 55

Prescription 55

PM360

SEPTEMBER 30, 2024

PM360’s Focus On section examines a specific area of the life sciences industry. In this issue, we take a closer look at the patient experience and how it is constantly evolving in the pharma industry. From conducting an easier process of scheduling doctors appointments to how patient feedback plays an important role in enhancing the experience, here is what our specialists had to say.

Patients 59

Patients Education Doctors Pharmaceutical 59

Pharmacy Times

SEPTEMBER 30, 2024

Aaron Adkisson, PharmD, discusses the importance of considering factors such as age, gender, and cardiovascular comorbidities when monitoring and managing cardiotoxic risks in patients with cancer. also emphasizing patient education on recognizing early heart failure symptoms.

Management 52

Management Education Patients 52

Rep-Lite

SEPTEMBER 30, 2024

Hiring the wrong candidate for a medical sales role can have significant repercussions for a company beyond what may appear on the surface. In an industry where knowledge, relationships, and compliance are critical, a bad hiring decision can lead to not only financial losses in both internal and external recruitment costs but also lasting damage to business operations and reputation.

Medical sales 52

Medical sales Sales Medical Recruitment 52

Advertisement

Distribution

Pharmacy Times

SEPTEMBER 30, 2024

There was a detrimental relationship between COVID-19 caseload and mortality observed across multiple types of hospitals.

52

52

PharmaTech

SEPTEMBER 30, 2024

In vitro transcription (IVT) is often used to make mRNA, and in co-transcriptional capping an analog cap can be used to cap the mRNA. This paper reviews the recent history of capping analogs in addition to a state-of-the-art approach to improve protein expression.

Manufacturing 52

Manufacturing 52

Pharmacy Times

SEPTEMBER 30, 2024

C. diff survivor and Peggy Lillis Foundation Board Member Maryann Webb discusses how her experience with the infection encouraged her to advocate for patients who are struggling to advocate for themselves.

Patients 52

Patients 52

Pharmaceutical Commerce

SEPTEMBER 30, 2024

Webinar Date/Time: Tue, Oct 22, 2024 11:00 AM EDT

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales